Younger patients with remitted primary anterior uveitis are at a higher risk of relapsing

Article

Young adults with remitted primary anterior uveitis pose a higher risk of relapsing than middle-aged adults.

Young adults with remitted primary anterior uveitis pose a higher risk of relapsing than middle-aged adults, according to an investigation featured in Ophthalmology.

Dr John H. Kempen et al., Department of Ophthalmology, The University of Pennsylvania, Philadelphia, Pennsylvania, USA, compiled a retrospective cohort study on 102 anterior uveitis patients. Each patient achieved remission during the primary episode of anterior uveitis within 90 days of diagnosis. Information was obtained via a standardized chart review and the main outcome measures included time to relapse of anterior uveitis and the risk factors contributing towards relapse.

The findings demonstrated a recurrence of anterior uveitis in 40 patients and a relapse incidence in 24% per patient, per year. Of the patients studied, 61% remained in remission at 1.5 years after remission.

The comparison of 18–35 year old patients with 35–55 year old patients revealed that younger adults presented with a significantly higher relapse risk than middle-aged adults.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.